ABPI guidance notes on joint working between pharmaceutical companies and the NHS and others for the benefit of patients

The NHS is changing rapidly and there is a desire on the part of Government and the NHS for the NHS to engage with the pharmaceutical industry on a broader agenda. The ABPI has introduced guidance to provide a framework and greater clarity about various aspects of joint working between the pharmaceutical industry and the NHS.